PIMJS
TEVA icon

PKO Investment Management Joint-Stock’s Teva Pharmaceuticals TEVA Stock Holding History

PKO Investment Management Joint-Stock’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$474K Buy
14,000
+3,000
+27% +$99.9K 0.03% 202
2026
Q1 		$331K Buy
11,000
+1,000
+10% +$32.2K 0.03% 197
2025
Q4 		$312K Sell
10,000
-5,000
-33% -$123K 0.02% 199
2025
Q3 		$303K Buy
+15,000
New +$263K 0.03% 189

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

PKO Investment Management Joint-Stock's TEVA Position: Q2 2026 in Review

PKO Investment Management Joint-Stock increased its Teva Pharmaceuticals (TEVA) stake by 27% in Q2 2026, buying an estimated $99.9K and bringing the position to 14,000 shares worth $474K. The position accounts for 0.03% of the portfolio, ranked #202.

PKO Investment Management Joint-Stock first reported a position in TEVA in Q3 2025 and has held it in 4 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • PKO Investment Management Joint-Stock held 14,000 shares of Teva Pharmaceuticals worth $474K as of Q2 2026.
  • PKO Investment Management Joint-Stock bought 3,000 Teva Pharmaceuticals shares in Q2 2026, an estimated $99.9K.
  • Teva Pharmaceuticals made up 0.03% of PKO Investment Management Joint-Stock's portfolio in Q2 2026, its #202 holding.
  • PKO Investment Management Joint-Stock first reported a position in Teva Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on PKO Investment Management Joint-Stock's 13F filing for Q2 2026, filed 20 Jul 2026.